Publication | Closed Access
Phase I study of corynebacterium parvum in patients with solid tumors.
17
Citations
0
References
1976
Year
Health SciencesSolid TumorsNineteen PatientsPathologyVarious Solid TumorsCorynebacterium ParvumMicrobiologyInfection ControlMedicineClinical MicrobiologyDrug Resistance
Nineteen patients with various solid tumors were treated with Corynebacterium parvum for 10 consecutive days at doses ranging from 0.5 to 6 mg/m2. Major toxic effects included rigors and cyanosis, hypertension, headache, nausea, and vomiting. Toxicity was maximal during the first 3 days of treatment and decreased or even disappeared when, on subsequent days, increasing doses of the vaccine were given. Objective tumor regressions were observed in four patients.